Menu
26/01/2005
Funding secured for cystic fibrosis researchers
Cystic fibrosis researchers from Queen's University have won a share of a major £500,000 funding grant.
The Cystic Fibrosis Trust was awarded £509,759 from the Big Lottery Fund to help improve the lives of disadvantaged children and young adults with the disease.
The condition, which is genetically inherited, causes the body to produce an abnormally thick, sticky mucus that clogs the lungs and leads to life-threatening lung infections.
Commenting on the award, Consultant Respiratory physician, Professor Stuart Elborn, who is part of the research team, said: "Transmission within the cystic fibrosis community of life-threatening lung infections can have a devastating effect on lives. This means that many individuals are often forced to live in isolation, unable to interact and share experiences with other cystic fibrosis sufferers.
"Thanks to the Big Lottery Fund award our ground-breaking research will investigate the spread of 'superbugs'. It will also improve speed and accuracy of diagnosis and treatment of respiratory infections. This will help those living with the UK's most common, life-threatening inherited disease have healthier and happier lives.”
The new medical project aims to improve the lives of those with the disease by helping develop faster and more accurate diagnosis of life-threatening lung infections. It also plans to identify virulent strains of bacteria and develop more effective drugs to control infection.
A total of 370 people in Northern Ireland suffer from the cystic fibrosis.
(MB/SP)
The Cystic Fibrosis Trust was awarded £509,759 from the Big Lottery Fund to help improve the lives of disadvantaged children and young adults with the disease.
The condition, which is genetically inherited, causes the body to produce an abnormally thick, sticky mucus that clogs the lungs and leads to life-threatening lung infections.
Commenting on the award, Consultant Respiratory physician, Professor Stuart Elborn, who is part of the research team, said: "Transmission within the cystic fibrosis community of life-threatening lung infections can have a devastating effect on lives. This means that many individuals are often forced to live in isolation, unable to interact and share experiences with other cystic fibrosis sufferers.
"Thanks to the Big Lottery Fund award our ground-breaking research will investigate the spread of 'superbugs'. It will also improve speed and accuracy of diagnosis and treatment of respiratory infections. This will help those living with the UK's most common, life-threatening inherited disease have healthier and happier lives.”
The new medical project aims to improve the lives of those with the disease by helping develop faster and more accurate diagnosis of life-threatening lung infections. It also plans to identify virulent strains of bacteria and develop more effective drugs to control infection.
A total of 370 people in Northern Ireland suffer from the cystic fibrosis.
(MB/SP)
Related Northern Ireland News Stories
Click here for the latest headlines.
13 November 2019
CF Drugs To Be Available Within Weeks
Clinicians will begin prescribing life-changing drugs to local Cystic Fibrosis patients in a matter of weeks, the Department of Health has confirmed. Orkambi, Symkevi and Kalydeco will be made available through a deal with manufacturer Vertex Pharmaceuticals which follows similar arrangements in England and Scotland.
CF Drugs To Be Available Within Weeks
Clinicians will begin prescribing life-changing drugs to local Cystic Fibrosis patients in a matter of weeks, the Department of Health has confirmed. Orkambi, Symkevi and Kalydeco will be made available through a deal with manufacturer Vertex Pharmaceuticals which follows similar arrangements in England and Scotland.
30 October 2019
Cystic Fibrosis Drugs To Be Made Available In NI
Life-saving drugs for the treatment of cystic fibrosis are to be made available in Northern Ireland. The Department of Health confirmed its intention to strike a deal for the supply of Orkambi and Symkevi to eligible local patients. The move follows a similar agreement in Scotland last month and with NHS England just last Thursday, 24 October.
Cystic Fibrosis Drugs To Be Made Available In NI
Life-saving drugs for the treatment of cystic fibrosis are to be made available in Northern Ireland. The Department of Health confirmed its intention to strike a deal for the supply of Orkambi and Symkevi to eligible local patients. The move follows a similar agreement in Scotland last month and with NHS England just last Thursday, 24 October.
05 November 2019
QUB Partakes In New Cystic Fibrosis Trial
Researchers at Queen's University Belfast have been involved in ground-breaking research that holds promise for a vast majority of those with cystic fibrosis.
QUB Partakes In New Cystic Fibrosis Trial
Researchers at Queen's University Belfast have been involved in ground-breaking research that holds promise for a vast majority of those with cystic fibrosis.
14 January 2022
Health Minister Confirms Extension To Use Of Cystic Fibrosis Treatment
Health Minister Robin Swann has announced that Kaftrio will be made available to suitable patients aged six years and older in Northern Ireland for the treatment of cystic fibrosis (CF).
Health Minister Confirms Extension To Use Of Cystic Fibrosis Treatment
Health Minister Robin Swann has announced that Kaftrio will be made available to suitable patients aged six years and older in Northern Ireland for the treatment of cystic fibrosis (CF).
25 October 2019
Call For Cystic Fibrosis Drugs To Be Extended To NI
Calls have emerged for lifesaving Cystic Fibrosis drugs to be made available in Northern Ireland following a landmark decision for provision on NHS England. A deal was struck with manufacturer Vertex Pharmaceuticals for supplies of Orkambi and Symkevi in England just weeks after the Scottish Government made the same move.
Call For Cystic Fibrosis Drugs To Be Extended To NI
Calls have emerged for lifesaving Cystic Fibrosis drugs to be made available in Northern Ireland following a landmark decision for provision on NHS England. A deal was struck with manufacturer Vertex Pharmaceuticals for supplies of Orkambi and Symkevi in England just weeks after the Scottish Government made the same move.
-
Northern Ireland WeatherToday:There will be a mixture of bright intervals and a few showers. Best of the sunny spells will be near the North Coast. Feeling on the cool side. Maximum temperature 10 °C.Tonight:Showers will gradually die out during the evening. A cold night with long clear spells leading to a touch of frost in places. Minimum temperature 0 °C.
